A freeze-fracture transmission electron microscopy and small angle x-ray diffraction study of the effects of albumin, serum, and polymers on clinical lung surfactant microstructure

Biophysical Journal

Volumn 93, Issue 1, 2007, Pages 123-139

  Braun, Andreas ^c   Stenger, Patrick C ^c   Warriner, Heidi E ^c   Zasadzinski, Joseph A ^c   Lu, Karen W ^a,b   Taeusch, H William ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

^c University of California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; HYALURONIC ACID; LUNG SURFACTANT; MACROGOL; POLYMER; PORACTANT;

ARTICLE; BILAYER MEMBRANE; DEHYDRATION; ELECTRICITY; FREEZE FRACTURE; IONIC STRENGTH; MACROMOLECULE; OSMOTIC PRESSURE; PULSATILE FLOW; RADIATION SCATTERING; SERUM; SURFACE TENSION; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

EID: 34447249724     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1529/biophysj.106.095513     Document Type: Article

References (105)

1. Clements, J. A., and M. E. Avery. 1998. Lung surfactant and neonatal respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 157:59-66.
2. Zasadzinski, J. A., J. Ding, H. E. Warriner, F. Bringezu, and A. J. Waring. 2001. The physics and physiology of lung surfactants. Curr. Opinion Coll. Int. Sci. 6:506-513.
3. Avery, M. E. 2000. Surfactant deficiency in hyaline membrane disease. Am. J. Respir. Crit. Care Med. 161:1074-1075.
4. Notter, R. H. 2000. Lung Surfactant: Basic Science and Clinical Applications. Marcel Dekker, New York.
5. Suresh, G. K., and R. F. Soll. 2005. Overview of surfactant replacement trials. J. Perinatol. 25:S40-S44.
6. Spragg, R. G., J. F. Lewis, H. D. Walmrath, J. Johannigman, G. Bellingan, P. F. Laterre, M. C. Witte, G. A. Richards, G. Rippin, G. Rathgeb, D. Hafner, F. J. Taut, and W. Seeger. 2004. Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. N. Engl. J. Med. 351:884-892.
7. Gregory, T., and K. Steinberg. 1997. Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 155:1309-1315.
8. Spragg, R. J., and R. M. Smith. 1998. Surfactant replacement in patients with ARDS: result of clinical trials. In Acute Respiratory Distress Syndrome: Cellular and Molecular Mechanisms and Clinical Management, vol. 297. S. Matalon and J. I. Sznajder, editors. Plenum Press, New York. 107-116.
9. Lu, K. W., H. William Taeusch, B. Robertson, J. Goerke, and J. A. Clements. 2000. Polymer-surfactant treatment of meconium-induced acute lung injury. Am. J. Respir. Crit. Care Med. 162:623-628.
10. Tashiro, K., T. Kobayashi, and B. Robertson. 2000. Dextran reduces surfactant inhibition by meconium. Acta Paediatr. 89:1439-1445.
11. Tashiro, K., X. G. Cui, T. Kobayashi, T. Curstedt, and B. Robertson. 2003. Modified protocols for surfactant therapy in experimental meconium aspiration syndrome. Biol. Neonate. 83:49-56.
12. Holm, B. A., G. Enhorning, and R. H. Notter. 1988. A biophysical mechanism by which plasma proteins inhibit lung surfactant activity. Chem. Phys. Lipids. 1988:49-55.
13. Taeusch, H. W. 2000. Treatment of acute (adult) respiratory distress syndrome: the holy grail of surfactant therapy. Biol. Neonate. 77(suppl. 1):2-8.
14. Lu, J. J., W. W. Y. Cheung, L. M. Y. Yu, Z. Policova, D. Li, M. L. Hair, and A. W. Neumann. 2002. The effect of dextran to restore the activity of pulmonary surfactant inhibited by albumin. Respir. Physiol. Neruobiol. 130:169-179.
15. Lu, J. J., L. M. Y. Yu, W. W. Y. Cheung, Z. Policova, D. Li, M. L. Hair, and A. W. Neumann. 2003. The effect of concentration on the bulk adsorption of bovine lipid extract surfactant. Colloids Surf. B. Biointerfaces. 29:119-130.
16. Lu, K., H. W. Taeusch, B. Robertson, J. Goerke, and J. A. Clements. 2001. Polyethylene glycol/surfactant mixtures improve lung function after HCl and endotoxin lung injuries. Am. J. Respir. Crit. Care Med. 164:1531-1536.
17. Taeusch, H. W., J. Bernadino de la Serna, J. Perez-Gil, C. Alonso, and J. A. Zasadzinski. 2005. Inactivation of pulmonary surfactant due to serum-inhibited adsorption and reversal by hydrophilic polymers: experimental. Biophys. J. 89:1769-1779.
18. Zasadzinski, J. A., T. F. Alig, C. Alonso, J. Bernadino de la Serna, J. Perez-Gil, H. W. Taeusch. 2005. Inhibition of pulmonary surfactant adsorption by serum and the mechanisms of reversal by hydrophilic polymers: theory. Biophys. J. 89:1621-1629.
19. Lu, K., J. Goerke, J. A. Clements, and H. W. Taeusch. 2005. Hyaluronan reduces surfactant inactivation in vitro. Pediatr. Res. 57:237-241.
20. Lu, J. J., L. Yu, W. W. Y. Cheung, I. Goldthorpe, Y. Zuo, Z. Policova, P. Cox, and A. W. Neumann. 2005. PEG enhances dynamic surface activity of a bovine lipid extract surfactant (BLES). Colloids Surf. B. Biointerfaces. 41:145-151.
21. Zuo, Y. Y., H. Alolabi, A. Shapel, N. Kang, Z. Policova, P. N. Cox, E. Acosta, M. L. Hair, and A. W. Neumann. 2006. Chitosan enhances the in vitro surface activity of dilute lung surfactant preparations and resists albumin-induced inactivation. Pediatr. Res. 60:125-130.
22. Kobayashi, T., K. Ohta, K. Tashiro, K. Nishizuka, W.-M. Chen, S. Ohmura, and K. Yamamoto. 1999. Dextran restores albumin-inhibited surface activity of pulmonary surfactant extract. J. Appl. Physiol. 86:1778-1784.
23. Lu, K., J. Goerke, J. A. Clements, and H. W. Taeusch. 2005. Hyaluronan reduces surfactant inhibition and improves rat lung function after meconium lung injury. Pediatr. Res. 58:206-210.
24. Lu, K., B. Robertson, and H. W. Taeusch. 2005. Dextran or polyethylene glycol added to Curosurf for treatment of meconium lung injury in rats. Biol. Neonate. 88:46-53.
25. Hyers, T. M. 1991. Adult respiratory distress syndrome: definition, risk factors and outcome. In Adult Respiratory Distress Syndrome, vol. 50. W. M. Zapol and F. Lemaire, editors. Marcel Dekker, New York. 23-33.
26. Anzueto, A. 2002. Surfactant supplementation in the lung. Respir. Care Clin. N. Am. 2:211-236.
27. Spragg, R. G. 1991. Abnormalities of lung surfactant function in patients with acute lung injury. In Adult Respiratory Distress Syndrome, vol. 50. W. M. Zapol and F. Lemaire, editors. Marcel Dekker, New York. 381-395.
28. McIntyre, R. C. Jr., E. J. Pulido, D. D. Bensard, B. D. Shames, and E. Abraham. 2000. Thirty years of clinical trials in acute respiratory distress syndrome. Crit. Care Med. 28:3314-3331.
29. Ishizaka, A., T. Matsuda, K. Albertine, H. Koh, S. Tasaka, N. Hasegawa, N. Kohno, T. Kotani, H. Morisakai, J. Takeda, M. Nakamura, X. Fang, T. Martin, M. Matthay, and S. Hashimoto. 2004. Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome. Am. J. Physiol. Lung Cell. Mol. Physiol. 286:L1088-L1094.
30. Warriner, H. E., J. Ding, A. J. Waring, and J. A. Zasadzinski. 2002. A concentration-dependent mechanism by which serum albumin inactivates replacement lung surfactants. Biophys. J. 82:835-842.
31. Holm, B. A., R. H. Notter, and J. N. Finkelstein. 1985. Surface property changes from interactions of albumin with natural lung surfactant and extracted lung lipids. Chem. Phys. Lipids. 38:287-298.
32. Cockshutt, A. M., J. Weitz, and F. Possmayer. 1990. Pulmonary surfactant-associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro. Biochemistry. 29:8424-8429.
33. Seeger, W., C. Grube, A. Gunther, and R. Schmidt. 1993. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. Eur. Respir. J. 6:971-977.
34. Seeger, W., A. Guenther, and C. Thede. 1992. Differential sensitivity to fibrinogen inhibition of SP-C- vs. SP-B-based surfactants. Am. J. Physiol. 262:L286-L291.
35. Amirkhanian, J. D., R. Bruni, A. J. Waring, and H. W. Taeusch. 1991. Inhibition of mixtures of surfactant lipids and synthetic sequences of surfactant proteins Sp-B and Sp-C. Biochim. Biophys. Acta. 1096:355-360.
36. Amirkhanian, J. D., R. Bruni, A. J. Waring, C. Navar, and H. W. Taeusch. 1993. Full length synthetic surfactant proteins, Sp-B and Sp-C, reduce surfactant inactivation by serum. Biochim. Biophys. Acta. 1168:315-320.
37. Rider, E., M. Ikegami, J. A. Whitsett, W. Hull, D. Absolom, and A. H. Jobe. 1993. Treatment responses to surfactants containing natural surfactant proteins in preterm rabbits. Am. Rev. Respir. Dis. 153:669-676.
38. Strayer, D., E. Herting, B. Sun, and B. Robertson. 1996. Antibody to surfactant protein A increases sensitivity of pulmonary surfactant to inactivation by fibrinogen in vivo. Am. Rev. Respir. Dis. 153:1116-1122.
39. Kobayashi, T., K. Tashiro, X. Cui, T. Konzaki, Y. Xu, C. Kabata, and K. Yamamoto. 2001. Experimental models of acute respiratory distress syndrome: clinical relevance and response to surfactant therapy. Biol. Neonate. 80:26-28.
40. Cui, X., K. Tashiro, H. Matsumoto, Y. Tsubokawa, and T. Kobayashi. 2003. Aerosolized surfactant and dextran for experimental acute respiratory distress syndrome caused by acidified milk in rats. Acta Anaethesiol. Scand. 47:853-860.
41. Yu, L. M. Y., J. J. Lu, I. W. Y. Chiu, K. S. Leung, Y. W. Chan, L. Zhang, Z. Policova, M. L. Hair, and A. W. Neumann. 2004. Polyethylene glycol enhances the surface activity of a pulmonary surfactant. Colloids Surf. B. Biointerfaces. 36:167-176.
42. Bae, C., A. Takahashi, S. Chida, and M. Sasaki. 1998. Morphology and function of pulmonary surfactant inhibited by meconium. Pediatr. Res. 44:187-191.
43. Schmiedl, A., N. Krug, and J. M. Hohfeld. 2004. Influence of plasma and inflammatory proteins on the ultrastructure of exogenous surfactant. J. Electron Microsc. (Tokyo). 53:407-416.
44. Ochs, M., M. Schuttler, G. Stichtenoth, and E. Herting. 2006. Morphological alterations of exogenous surfactant inhibited by meconium can be prevented by dextran. Respir. Res. 7:86-95.
45. Hayat, M. 1989. Principles and Techniques of Electron Microscopy: Biological Applications, 3rd ed. CRC Press, Boca Raton, FL.
46. Zasadzinski, J., C. Stratton, and D. Heetderks. 1987. Liquid crystal morphology and defects in in vivo human and mammalian phosphatidylcholine lung multilamellar surfactant. Langmuir. 3:592-595.
47. Stratton, C. J., J. A. Zasadzinski, and D. Elkins. 1988. Lung lamellar body amphiphilic topography: a morphological evaluation using the continuum theory of liquid crystals: I. Closed surfaces: closed spheres, concentric tori, and Dupin cyclides. Anat. Rec. 221:503-519.
48. Zasadzinski, J. A., C. J. Stratton, and R. Rudolph. 1988. Lung lamellar body amphiphilic topography: a morphological evaluation using the continuum theory of liquid crystals: II. Disclinations, edge dislocations, and irregular defects. Anat. Rec. 221:520-532.
49. Zasadzinski, J. A., and S. M. Bailey. 1989. Applications of freeze-fracture replication to problems in materials and colloid science. J. Electron Microsc. Tech. 13:309-334.
50. Zasadzinski, J. A., L. E. Scriven, and H. T. Davis. 1985. Liposome structure and defects. Philos. Mag. A. 51:287-302.
51. Spector, M. S., J. A. Zasadzinski, and M. B. Sankaram. 1996. Topology of multivesicular liposomes, a model biliquid foam. Langmuir. 12:4704-4708.
52. Keller, S. L., P. Boltenhagen, D. J. Pine, and J. A. Zasadzinski. 1998. Direct observation of shear induced structures in wormlike micellar solutions by freeze-fracture electron microscopy. Phys. Rev. Lett. 80:2725-2728.
53. Keller, S. L., H. E. Warriner, C. R. Safinya, and J. A. Zasadzinski. 1997. Direct observation of a defect mediated viscoelastic transition in a hydrogel of lipid membranes and polymer lipids. Phys. Rev. Lett. 78:4781-4784.
54. Walker, S. A., M. T. Kennedy, and J. A. Zasadzinski. 1997. Encapsulation of bilayer vesicles by self-assembly. Nature. 387:61-64.
55. Coldren, B. A., R. van Zanten, M. J. Mackel, J. A. Zasadzinski, and H. T. Jung. 2003. From vesicle size distributions to bilayer elasticity via cryo-transmission and freeze-fracture electron microscopy. Langmuir. 19:5632-5639.
56. Coldren, B. A., H. E. Warriner, R. van Zanten, J. A. Zasadzinski, and E. B. Sirota. 2006. Zero spontaneous curvature and its effects on lamellar phase morphology and vesicle size distributions. Langmuir. 22:2472-2481.
57. Kaler, E. W., A. K. Murthy, B. E. Rodriguez, and J. A. N. Zasadzinski. 1989. Spontaneous vesicle formation in aqueous mixtures of single-tailed surfactants. Science. 245:1371-1374.
58. Bailey, S. M., S. Chiruvolu, J. N. Israelachvili, and J. A. Zasadzinski. 1990. Measurements of forces involved in vesicle adhesion using freeze-fracture electron microscopy. Langmuir. 6:1326-1329.
59. Zasadzinski, J., J. Schneir, J. Gurley, V. Elings, and P. K. Hansma. 1988. Scanning tunneling microscopy of freeze-fracture replicas of biomembranes. Science. 239:1014-1015.
60. Spector, M. S., E. Naranjo, S. Chiruvolu, and J. A. Zasadzinski. 1994. Conformations of a tethered membrane: crumpling in graphitic oxide. Phys. Rev. Lett. 73:2867-2870.
61. Sammon, M. J., J. A. Zasadzinski, and M. R. Kuzma. 1986. Electron microscope observation of the smectic-nematic transition in a lyotropic liquid crystal. Phys. Rev. Lett. 57:2834-2837.
62. Zasadzinski, J. A., and M. B. Schneider. 1987. Ripple wavelength, amplitude, and configuration in lyotropic liquid-crystals as a function of effective headgroup size. J. Physique (France). 48:2001-2011.
63. Zasadzinski, J. A. 1986. TEM observations of sonication induced changes in liposome structure. Biophys. J. 49:1119-1130.
64. Bloom, B. T., J. Kattwinkel, R. T. Hall, P. M. Delmore, E. A. Egan, J. R. Trout, M. H. Malloy, D. R. Brown, I. R. Holzman, C. H. Coghill, W. A. Carlo, A. K. Pramanik, M. A. McCaffree, P. L. Toubas, S. Laudert, L. L. Gratny, K. B. Weatherstone, J. H. Seguin, L. D. Willett, G. R. Gutcher, D. H. Mueller, and W. H. Topper. 1997. Comparison of Infasurf (calf lung surfactant extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome. Pediatrics. 100:31-38.
65. Ramanathan, R., M. Rasmussen, D. R. Gerstmann, N. Finer, K. Sekar, and North American Study Group. 2004. A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants. Am. J. Perinatol. 21:109-119.
66. Bernhard, W., J. Mottaghian, A. Gebert, G. A. Rau, H. von der Hardt, and C. F. Poets. 2000. Commercial versus native surfactants. Surface activity, molecular components, and the effect of calcium. Am. J. Respir. Crit. Care Med. 162:1524-1533.
67. Parsegian, V. A., R. P. Rand, N. L. Fuller, and D. C. Rau. 1986. Osmotic stress for the direct measurement of intermolecular forces. Methods Enzymol. 127:400-416.
68. Parsegian, V. A., R. P. Rand, and D. C. Rau. 2000. Osmotic stress, crowding, preferential hydration, and binding: a comparison of perspectives. Proc. Natl. Acad. Sci. USA. 97:3987-3992.
69. Parsegian, V. A., R. P. Rand, and N. L. Fuller. 1991. Direct osmotic stress measurements of hydration and the electrostatic double layer forces between bilayers of double-chained ammonium acetate surfactants. J. Phys. Chem. 95:4777-4782.
70. Bligh, E., and W. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911-917.
71. Putz, G., J. Goerke, H. W. Taeusch, and J. A. Clements. 1994. Comparison of captive and modified pulsating bubble surfactometers. J. Appl. Physiol. 76:1425-1431.
72. Warriner, H. E., S. L. Keller, S. H. J. Idziak, N. L. Slack, P. Davidson, J. A. Zasadzinski, and C. R. Safinya. 1998. The influence of polymer molecular weight in lamellar gels based on PEG lipids. Biophys. J. 75:272-293.
73. Kisak, E., B. Coldren, C. Boyer, C. Evans, and J. A. Zasadzinski. 2004. The vesosome - a multicompartment drug delivery vehicle. Curr. Med. Chem. 11:1241-1253.
74. Kisak, E., B. Coldren, and J. A. Zasadzinski. 2002. Nano-compartments enclosing vesicles, colloids and macromolecules via interdigitated lipid bilayers. Langmuir. 18:284-288.
75. Viswanathan, R., L. L. Madsen, J. A. Zasadzinski, and D. K. Schwartz. 1995. Liquid to hexatic to crystalline order in Langmuir-Blodgett films. Science. 269:51-54.
76. Hui, S. W., R. Viswanathan, J. A. Zasadzinski, and J. N. Israelachvili. 1995. The structure and stability of phospholipid bilayers by AFM. Biophys. J. 68:171-178.
77. Krishnan, A., J. Sturgeon, C. A. Siedlicki, and E. A. Vogler. 2003. Scaled interfacial activity of proteins at the liquid-vapor interface. J. Biomed. Mater. Res. 68A:544-557.
78. Stenger, P. C., and J. A. Zasadzinski. 2007. Enhanced surfactant adsorption via polymer depletion forces: a simple model for reversing surfactant inhibition in acute respiratory distress syndrome. Biophys. J. 92:3-9.
79. Asakura, S., and F. Oosawa. 1958. Interactions between particles suspended in solutions of macromolecules. J. Polym. Sci. [B]. 33:183-192.
80. Israelachvili, J. N. 1992. Intermolecular and Surface Forces, 2nd ed. Academic Press, London.
81. Lee, K. Y. C., A. Gopal, A. Von Nahmen, J. A. Zasadzinski, J. Majewski, G. S. Smith, P. B. Howes, and K. Kjaer. 2002. Influence of palmitic acid and hexadecanol on the phase transition temperature and molecular packing of dipalmitoylphophatidyl-choline monolayers at the air-water interface. J. Chem. Phys. 116:774-783.
82. Bringezu, F., J. Q. Ding, G. Brezesinski, A. J. Waring, and J. A. Zasadzinski. 2002. Influence of pulmonary surfactant protein B on model lung surfactant monolayers. Langmuir. 18:2319-2325.
83. Helfrich, W. 1973. Elastic properties of lipid bilayers: theory and possible experiments. Z. Naturfosch. 28c:693-703.
84. Helfrich, W. 1978. Steric interaction of fluid membranes in multilayer systems. Z. Naturforschung. 33A:305-315.
85. Evans, E., and W. Rawicz. 1990. Entropy driven tension and bending elasticity in condensed fluid membranes. Phys. Rev. Lett. 64:2094-2097.
86. Rawicz, W., K. C. Olbrich, T. McIntosh, D. Needham, and E. Evans. 2000. Effect of chain length and unsaturation on elasticity of lipid bilayers. Biophys. J. 79:328-339.
87. Jung, H.-T., B. Coldren, J. A. Zasadzinski, D. Iampietro, and E. W. Kaler. 2001. Origins of stability of spontaneous vesicles. Proc. Natl. Acad. Sci. USA. 98:1353-1357.
88. Jung, H. T., S. Y. Lee, B. Coldren, J. A. Zasadzinski, and E. W. Kaler. 2002. Gaussian curvature and the equilibrium between cylinders, discs and spheres. Proc. Natl. Acad. Sci. USA. 99:15318-15322.
89. Harris, J. 1992. Introduction to biotechnical and biomedical applications of poly(ethylene glycol). In Poly(Ethylene Glycol) Chemistry: Biotechnical and Biomedical Applications. J. Harris, editor. Plenum Press, New York. 1-12.
90. Turino, G., and J. Cantor. 2003. Hyaluronan in respiratory injury and repair. Am. J. Respir. Crit. Care Med. 167:1169-1175.
91. Sahu, S., A. Tanswell, and W. Lynn. 1980. Isolation and characterization of glycoaminoglycans secreted by human fetal type II pneumocytes in culture. J. Cell Sci. 42:183-188.
92. Skinner, S., M. Post, J. Torday, A. Stiles, and B. Smith. 1987. Characterization of proteogylcans synthesized by fetal rat lung type II pneumocytes in vitro and the effects of cortisol. Exp. Lung Res. 12:254-264.
93. Bray, B. A. 2001. The role of hyaluronan in the pulmonary alveolus. J. Theor. Biol. 210:121-130.
94. Mascarenhas, M. M., R. M. Day, C. D. Ochoa, W. I. Choi, L. Yu, B. Ouyang, H. G. Garg, C. A. Hales, and D. A. Quinn. 2004. Low molecular weight hyaluronan from stretched lung enhances interleukin-8 expression. Am. J. Respir. Cell Mol. Biol. 30:51-60.
95. Cantor, J. O., J. M. Cerreta, M. Ochoa, S. Ma, T. Chow, G. Grunig, and G. M. Turino. 2005. Aerosolized hyaluronan limits airspace enlargement in a mouse model of cigarette smoke-induced pulmonary emphysema. Exp. Lung. Res. 31:417-430.
96. Cantor, J., B. Shteyngart, J. Cerreta, M. Liu, G. Armand, and G. Turino. 2000. The effect of hyaluronan on elastic fiber injury in vitro and elastase-induced airspace enlargement in vivo. Proc. Soc. Exp. Biol. Med. 225:65-71.
97. Forteza, R., T. Lieb, T. Aoki, R. Savani, G. Conner, and M. Salathe. 2001. Hyaluronan serves a novel role in airway mucosal host defense. FASEB J. 21:79-86.
98. Nitzan, D. W., U. Nitzan, P. Dan, and S. Yedgar. 2001. The role of hyaluronic acid in protecting surface-active phospholipids from lysis by exogenous phospholipase A(2). Rheumatology (Oxford). 40:336-340.
99. Kaplan, P. D., J. L. Rourke, A. G. Yodh, and D. J. Pine. 1994. Entropically driven surface phase separation in binary colloidal mixtures. Phys. Rev. Lett. 72:582-585.
100. Zimmerman, S. B., and A. P. Minton. 1993. Macromolecular crowding: biochemical, biophysical, and physiological consequences. Annu. Rev. Biophys. Biomol. Struct. 22:27-65.
101. Kaplan, P. D., L. P. Faucheux, and A. J. Libchaber. 1994. Direct observation of the entropic potential in a binary suspension. Phys. Rev. Lett. 73:2793-2796.
102. Dinsmore, A. D., D. T. Wong, P. Nelson, and A. G. Yodh. 1998. Hard spheres in vesicles: curvature-induced forces and particle induced curvature. Phys. Rev. Lett. 80:409-412.
103. Dinsmore, A. D., A. G. Yodh, and D. J. Pine. 1996. Entropic control of particle motion using passive surface microstructures. Nature. 383:239-242.
104. Postle, A. D., E. L. Heeley, and D. C. Wilton. 2001. A comparison of the molecular species compositions of mammalian lung surfactant phospholipids. Comp. Biochem. Phys. A. 129:65-73.
105. Robertson, B., and H. L. Halliday. 1998. Principles of surfactant replacement. Biochim. Biophys. Acta. 1408:346-361.